AksharChem India [AKSHARCHEM] vs Chemo-Pharma [CPL] Detailed Stock Comparison
AksharChem India
NSE
Loading...
Chemo-Pharma
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: AksharChem India wins in 9 metrics, Chemo-Pharma wins in 10 metrics, with 0 ties. Chemo-Pharma appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AksharChem India | Chemo-Pharma | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 50.11 | 11.68 | Chemo-Pharma |
| Price-to-Book Ratio | 0.82 | 2.39 | AksharChem India |
| Debt-to-Equity Ratio | 25.32 | 44.70 | AksharChem India |
| PEG Ratio | -1.33 | 0.59 | AksharChem India |
| EV/EBITDA | 11.34 | 13.07 | AksharChem India |
| Profit Margin (TTM) | 1.21% | 11.11% | Chemo-Pharma |
| Operating Margin (TTM) | 2.50% | 9.62% | Chemo-Pharma |
| EBITDA Margin (TTM) | 2.50% | 9.62% | Chemo-Pharma |
| Return on Equity | 1.81% | 20.97% | Chemo-Pharma |
| Return on Assets (TTM) | 1.15% | 11.26% | Chemo-Pharma |
| Free Cash Flow (TTM) | $-93.80M | $41.66M | Chemo-Pharma |
| Dividend Yield | 0.20% | N/A | N/A |
| 1-Year Return | -14.23% | -11.82% | Chemo-Pharma |
| Price-to-Sales Ratio (TTM) | 0.62 | 1.32 | AksharChem India |
| Enterprise Value | $2.78B | $4.38B | Chemo-Pharma |
| EV/Revenue Ratio | 0.78 | 1.50 | AksharChem India |
| Gross Profit Margin (TTM) | 42.61% | 29.30% | AksharChem India |
| Revenue per Share (TTM) | $446 | $51 | AksharChem India |
| Earnings per Share (Diluted) | $5.40 | $5.49 | Chemo-Pharma |
| Beta (Stock Volatility) | 0.12 | 0.23 | AksharChem India |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
AksharChem India vs Chemo-Pharma Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AksharChem India | 1.29% | 0.20% | -0.79% | -8.58% | 27.30% | -11.67% |
| Chemo-Pharma | 4.12% | 2.98% | -2.65% | -13.55% | -20.39% | -42.60% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AksharChem India | -14.23% | -19.36% | 25.48% | -62.78% | -62.78% | -62.78% |
| Chemo-Pharma | -11.82% | 289.27% | 113.29% | 483.06% | 1,203.91% | 1,203.91% |
News Based Sentiment: AksharChem India vs Chemo-Pharma
AksharChem India
News based Sentiment: MIXED
October saw AksharChem identified as a monthly loser, but an investment report suggested a possible cyclical uptrend. This creates a mixed narrative, balancing recent negative performance with potential future gains, making it a moderately important month for investors.
Chemo-Pharma
News based Sentiment: MIXED
September brought a mix of developments for both companies, with Chemo-Pharma facing volatility and reporting issues, while Captain Polyplast showed short-term gains amidst a longer-term decline. The month lacked any major catalysts or game-changing events, resulting in a neutral overall investment story.
Performance & Financial Health Analysis: AksharChem India vs Chemo-Pharma
| Metric | AKSHARCHEM | CPL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.20B | ₹3.84B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,034 | 57,652 |
| 90 Day Avg. Volume | 11,633 | 42,412 |
| Last Close | ₹270.60 | ₹66.76 |
| 52 Week Range | ₹195.00 - ₹368.10 | ₹58.41 - ₹128.00 |
| % from 52W High | -26.49% | -47.84% |
| All-Time High | ₹945.00 (May 15, 2017) | ₹128.00 (Jan 06, 2025) |
| % from All-Time High | -71.37% | -47.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.08% |
| Quarterly Earnings Growth | -0.38% | 0.34% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.11% |
| Operating Margin (TTM) | 0.03% | 0.10% |
| Return on Equity (TTM) | 0.02% | 0.21% |
| Debt to Equity (MRQ) | 25.32 | 44.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹328.90 | ₹26.86 |
| Cash per Share (MRQ) | ₹2.25 | ₹1.01 |
| Operating Cash Flow (TTM) | ₹66.50M | ₹277.99M |
| Levered Free Cash Flow (TTM) | ₹47.70M | ₹313.23M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.20% | N/A |
| Last 12-Month Dividend | ₹0.50 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: AksharChem India vs Chemo-Pharma
| Metric | AKSHARCHEM | CPL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 50.11 | 11.68 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -1.33 | 0.59 |
| Price to Sales (TTM) | 0.62 | 1.32 |
| Price to Book (MRQ) | 0.82 | 2.39 |
| Market Capitalization | ||
| Market Capitalization | ₹2.20B | ₹3.84B |
| Enterprise Value | ₹2.78B | ₹4.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.78 | 1.50 |
| Enterprise to EBITDA | 11.34 | 13.07 |
| Risk & Other Metrics | ||
| Beta | 0.12 | 0.23 |
| Book Value per Share (MRQ) | ₹328.90 | ₹26.86 |
Financial Statements Comparison: AksharChem India vs Chemo-Pharma
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AKSHARCHEM | CPL |
|---|---|---|
| Revenue/Sales | ₹969.62M | ₹697.42M |
| Cost of Goods Sold | ₹556.45M | ₹493.08M |
| Gross Profit | ₹413.17M | ₹204.34M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹24.25M | ₹67.12M |
| EBITDA | ₹64.50M | ₹79.31M |
| Pre-Tax Income | ₹10.32M | ₹55.13M |
| Income Tax | ₹3.21M | ₹12.13M |
| Net Income (Profit) | ₹7.11M | ₹42.99M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AKSHARCHEM | CPL |
|---|---|---|
| Cash & Equivalents | ₹1.44M | ₹12.05M |
| Total Current Assets | ₹1.34B | ₹2.51B |
| Total Current Liabilities | ₹1.15B | ₹1.17B |
| Long-Term Debt | ₹133.16M | ₹109.50M |
| Total Shareholders Equity | ₹2.64B | ₹1.49B |
| Retained Earnings | ₹1.70B | ₹1.08B |
| Property, Plant & Equipment | ₹2.31B | ₹48.61M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AKSHARCHEM | CPL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AKSHARCHEM | CPL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 4,034 | 57,652 |
| Average Daily Volume (90 Day) | 11,633 | 42,412 |
| Shares Outstanding | 8.03M | 57.55M |
| Float Shares | 2.29M | 17.06M |
| % Held by Insiders | 0.69% | 0.69% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: AksharChem India vs Chemo-Pharma
| Metric | AKSHARCHEM | CPL |
|---|---|---|
| Last 12-Month Dividend | ₹0.50 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.20% | N/A |
| 3-Year Avg Annual Dividend | ₹0.50 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.15% | N/A |
| 3-Year Total Dividends | ₹1.50 | ₹0.00 |
| Ex-Dividend Date | Sep 23, 2024 | N/A |